An Extension Study of Donidalorsen (IONIS-PKK-LRx) in Participants With Hereditary Angioedema
Clinical trial NCT04307381 · COMPLETED
Trial details
- NCT number
- NCT04307381
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-31
- Primary completion
- 2025-01-24
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.